Skip to main content

Gland Pharma makes decent debut, shares list at 14% premium vs issue price

The Rs 6,480-crore IPO of Gland Pharma managed to sail through solely on the back of institutional investor demand.

from Home Page https://ift.tt/3fhqh9t

Comments

Popular posts from this blog